Progressive hemifacial atrophy. A natural history study.
OBJECTIVE
To describe two very different natural history courses in 2 patients with hemifacial atrophy. Progressive hemifacial atrophy (Parry-Romberg syndrome, Romberg syndrome, PHA) is characterized by slowly progressive atrophy, frequently involving only one side of the face, primarily affecting the subcutaneous tissue and fat. The onset usually occurs during the first 2 decades of life. The cause and pathophysiology are unknown. Ophthalmic involvement is common, with progressive enophthalmos a frequent finding. Pupillary disturbances, heterochromia, uveitis, pigmentary disturbances of the ocular fundus, and restrictive strabismus have also been reported. Neurologic findings may be present, but the natural history and progression of ocular findings are often not described in the literature.


METHODS
We studied the records and present findings of 2 patients with progressive hemifacial atrophy who were observed in our institution over a 10-year period.


RESULTS
Both patients showed progression of ophthalmic findings, primarily on the affected side. One patient has had chronic uveitis with secondary cataract and glaucoma, in addition to retinal pigmentary changes. She also had a third-nerve paresis of the contralateral eye and mild seizure activity. The other patient had mild uveitis, some progression of unilateral retinal pigmentary changes, and a significant increase in hyperopia in the affected eye, in addition to hypotony at age 19 without a clear cause, but with secondary retinal and refractive changes.


CONCLUSIONS
Ocular manifestations of progressive hemifacial atrophy are varied, but can progress from mild visual impairment to blindness.
Miller
M T
MT
Department of Ophthalmology and Visual Sciences Eye and Ear Infirmary University of Illinois at Chicago, USA.
Spencer
M A
MA
D000328:Adult; D002648:Child; D005128:Eye Diseases / Q000209:etiology / Q000503:physiopathology*; D005150:Facial Hemiatrophy / Q000209:etiology* / Q000503:physiopathology*; D005260:Female; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D008297:Male